Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines-Reference-Cited by-同舟云学术

Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines

Published:2024-04-15 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Russell Colin A.¹,Fouchier Ron A. M.²,Ghaswalla Parinaz³,Park Yoonyoung³,Vicic Nevena³,Ananworanich Jintanat³,Nachbagauer Raffael³,Rudin Deborah³^ORCID

Affiliation:

1. Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands

2. Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands

3. Moderna, Inc., Cambridge, MA, USA

Funder

Moderna, Inc

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2336357

Reference113 articles.

1. Current and future influenza vaccines

2. Vaccines against influenza: WHO position paper - May 2022;World Health Organization;Weekly Epidemiological Record,2022

3. Global and national influenza-associated hospitalisation rates: Estimates for 40 countries and administrative regions

4. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

5. Centers for Disease Control and Prevention. Estimated flu-related illnesses medical visits hospitalizations and deaths in the United States — 2019–2020 flu season. Vol. 2022. 2022 Oct 7. https://www.cdc.gov/flu/about/burden/2019-2020.html.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine;Drugs;2024-08-21

2. Host Innate Antiviral Response to Influenza A Virus Infection: From Viral Sensing to Antagonism and Escape;Pathogens;2024-07-03